EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
174 hedge funds and large institutions have $832M invested in Eagle Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 55 increasing their positions, 62 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $853M → $832M (-$20.7M)
11% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 62
Holders
174
Holding in Top 10
5
Calls
$7.07M
Puts
$6.34M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$12.9M | |
| 3 | +$6.6M | |
| 4 |
CEI
Clark Estates Inc
New York
|
+$2.96M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$2.87M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$8.85M | |
| 3 | -$5.3M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$4.98M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$3.4M |